Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland.

Nordmann, Patrice; Bouvier, Maxime; Poirel, Laurent

Nordmann, Patrice; Bouvier, Maxime; Poirel, Laurent.

Nordmann P; Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Bouvier M; Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland.
Poirel L; Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.

Eur J Clin Microbiol Infect Dis ; 42(9): 1145-1152, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37566365

Asunto(s)

Antibacterianos; Ceftazidima; Humanos; Meropenem/farmacología; Suiza; Antibacterianos/farmacología; Ceftazidima/farmacología; beta-Lactamasas; Proteínas Bacterianas/genética; Combinación de Medicamentos; Imipenem/farmacología; Pruebas de Sensibilidad Microbiana; Klebsiella pneumoniae

Palabras clave

Avibactam; Carbapenemase; Ceftazidime; Enterobacterales; Imipenem; Meropenem; Relebactam; Vaborbactam

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ceftazidima / Antibacterianos Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google